Millstone Evans Group LLC purchased a new position in STERIS plc (NYSE:STE – Free Report) in the fourth quarter, HoldingsChannel reports. The fund purchased 751 shares of the medical equipment provider’s stock, valued at approximately $154,000.
Other hedge funds and other institutional investors have also made changes to their positions in the company. Franklin Resources Inc. increased its stake in shares of STERIS by 171.2% in the third quarter. Franklin Resources Inc. now owns 838,569 shares of the medical equipment provider’s stock worth $191,370,000 after buying an additional 529,308 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. increased its stake in shares of STERIS by 30.8% in the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 10,970 shares of the medical equipment provider’s stock worth $2,275,000 after buying an additional 2,583 shares during the last quarter. Wilmington Savings Fund Society FSB bought a new stake in shares of STERIS in the third quarter worth $9,949,000. Public Sector Pension Investment Board increased its stake in shares of STERIS by 13.2% in the third quarter. Public Sector Pension Investment Board now owns 4,283 shares of the medical equipment provider’s stock worth $1,039,000 after buying an additional 500 shares during the last quarter. Finally, Merit Financial Group LLC acquired a new position in STERIS in the fourth quarter worth $260,000. Institutional investors own 94.69% of the company’s stock.
Wall Street Analysts Forecast Growth
A number of research firms have commented on STE. JMP Securities reaffirmed a “market outperform” rating and issued a $265.00 price objective on shares of STERIS in a report on Thursday, February 6th. Piper Sandler lifted their price objective on shares of STERIS from $260.00 to $265.00 and gave the stock an “overweight” rating in a report on Monday, February 3rd. Finally, Stephens reissued an “overweight” rating and set a $240.00 price target on shares of STERIS in a report on Thursday, February 6th. One analyst has rated the stock with a hold rating and five have given a buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $258.75.
STERIS Stock Performance
Shares of STE opened at $220.34 on Friday. STERIS plc has a 1 year low of $197.82 and a 1 year high of $248.24. The company has a market cap of $21.65 billion, a price-to-earnings ratio of 46.78 and a beta of 0.92. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.40 and a current ratio of 2.13. The firm has a fifty day moving average of $221.02 and a 200-day moving average of $221.97.
STERIS (NYSE:STE – Get Free Report) last posted its quarterly earnings data on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share for the quarter, missing the consensus estimate of $2.33 by ($0.01). STERIS had a return on equity of 13.91% and a net margin of 8.66%. As a group, equities analysts anticipate that STERIS plc will post 9.08 earnings per share for the current year.
STERIS Dividend Announcement
The business also recently disclosed a quarterly dividend, which was paid on Friday, March 21st. Investors of record on Thursday, February 20th were issued a $0.57 dividend. This represents a $2.28 annualized dividend and a yield of 1.03%. The ex-dividend date was Thursday, February 20th. STERIS’s payout ratio is currently 48.41%.
STERIS Company Profile
STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.
Featured Articles
- Five stocks we like better than STERIS
- What Are Earnings Reports?
- Why Williams-Sonoma Will Hit Fresh Highs in 2025
- P/E Ratio Calculation: How to Assess Stocks
- Alphabet Stock Becomes a Low-Risk, High-Reward Play
- 3 Dividend Kings To Consider
- Affirm Stock: Should You Buy the Dip After Walmart Setback?
Want to see what other hedge funds are holding STE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for STERIS plc (NYSE:STE – Free Report).
Receive News & Ratings for STERIS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS and related companies with MarketBeat.com's FREE daily email newsletter.